The blood pressure drug Losartan may be able to block a gene found in the blood, angiotensin II receptor type 1 (AGTR1), and improve the effectiveness of chemotherapy, according to a study published June 19 in Science Translational Medicine.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
